EnGeneIC

0 followers


EnGeneIC develops and commercializes the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells.

Headquarters

Sydney, Australia

Employees

11-50

Links

Org chart

CEOs

Collapse
Nick Rengel
SVP, Business Development
Nancy Mugridge
SVP, Pharma Alliances
Ilya Sedliarou
SVP, Antibody Science
Juan Dux-Santoy
SVP, Manufacturing
Scott Pattison
VP, Translational & Clinical Operations
Joshua Barnes
VP, Clinical Research